Drug treatment of epilepsy in the century of the ILAE: The second 50 years, 1959-2009

Epilepsia

Volumn 50, Issue SUPPL. 3, 2009, Pages 93-130

  Shorvon, Simon D ^a,b  

^a NATIONAL HOSPITAL FOR NEUROLOGY AND NEUROSURGERY   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Antiepileptic drugs; Epilepsy; History; International League Against Epilepsy; Treatment gap

Indexed keywords

ACETAZOLAMIDE; ANTICONVULSIVE AGENT; BROMINE DERIVATIVE; CARBAMAZEPINE; CHLORDIAZEPOXIDE; CLOBAZAM; CLONAZEPAM; DEXAMPHETAMINE; DIAZEPAM; ETHOSUXIMIDE; ETHOTOIN; ETIRACETAM; FELBAMATE; GABAPENTIN; LAMOTRIGINE; MEPACRINE; MEPHENYTOIN; MESUXIMIDE; METHARBITAL; METHYLPHENOBARBITAL; OXCARBAZEPINE; PARAMETHADIONE; PEGANONE; PENTETRAZOLE; PHENACEMIDE; PHENOBARBITAL; PHENSUXIMIDE; PHENYTOIN; PREGABALIN; PRIMIDONE; PROGABIDE; RUFINAMIDE; STIRIPENTOL; SULTIAME; TOPIRAMATE; TRIMETHADIONE; UNCLASSIFIED DRUG; UNINDEXED DRUG; VALPROATE SEMISODIUM; VALPROIC ACID; VIGABATRIN; VINPAT; ZONISAMIDE;

ABSENCE; AGGRESSION; AGRANULOCYTOSIS; ANTICONVULSANT THERAPY; ARTICLE; BLOOD DYSCRASIA; BLOOD TOXICITY; BRAIN DISEASE; CLINICAL TRIAL; COGNITIVE DEFECT; DAY BLINDNESS; DIET THERAPY; DISORDERS OF AMINO ACID AND PROTEIN METABOLISM; DIZZINESS; DROWSINESS; DRUG BLOOD LEVEL; DRUG EFFICACY; DRUG ERUPTION; DRUG HALF LIFE; DRUG MEGADOSE; DRUG SAFETY; DRUG SUBSTITUTION; DRUG TREATMENT FAILURE; ENDOCRINE DISEASE; EPILEPSY; EXFOLIATIVE DERMATITIS; FOCAL EPILEPSY; GASTROINTESTINAL SYMPTOM; GRAND MAL EPILEPSY; GRAND MAL SEIZURE; HAIR DISEASE; HUMAN; HYGIENE; KETOGENIC DIET; LEARNING DISORDER; LEUKOPENIA; LIFESTYLE MODIFICATION; LIVER DYSFUNCTION; LIVER FAILURE; LIVER TOXICITY; LUPUS LIKE SYNDROME; MALFORMATION SYNDROME; MENINGOMYELOCELE; MYOCLONUS EPILEPSY; NAUSEA; NEURAL TUBE DEFECT; NONHUMAN; OVARY POLYCYSTIC DISEASE; PANCREATITIS; PETIT MAL; PRESCRIPTION; PRIORITY JOURNAL; PSYCHOSIS; PSYCHOTHERAPY; RESTLESSNESS; SIDE EFFECT; STARVATION; TERATOGENESIS; TONIC CLONIC SEIZURE; TRIGEMINUS NEURALGIA; UNITED STATES; UNSPECIFIED SIDE EFFECT; WEAKNESS; WEIGHT CHANGE; WEST SYNDROME;

ADVERTISING AS TOPIC; ANTICONVULSANTS; EPILEPSY; HISTORY, 20TH CENTURY; HISTORY, 21ST CENTURY; HUMANS; NATIONAL INSTITUTES OF HEALTH (U.S.); TEXTBOOKS AS TOPIC; UNITED STATES; VALPROIC ACID;

EID: 62149128648     PISSN: 00139580     EISSN: 15281167     Source Type: Journal    
DOI: 10.1111/j.1528-1167.2009.02042.x     Document Type: Article

References (209)

1. Adab N., Jacoby A, Smith D, Chadwick D 2001) Additional educational needs in children born to mothers with epilepsy. J Neurol Neurosurg Psychiatry 70 : 15 21.
2. Anhut H, Ashman P, Feuerstein TJ, Sauermann W, Saunders M, Schmidt B 1994) Gabapentin (Neurontin) as add-on therapy in patients with partial seizures: a double-blind, placebo-controlled study: the International Gabapentin Study Group. Epilepsia 35 : 795 801.
3. Appleton R, Fichtner K, LaMoreaux L, Alexander J, Halsall G, Murray G, Garofalo E 1999) Gabapentin as add-on therapy in children with refractory partial seizures: a 12-week, multicentre, double-blind, placebo-controlled study: Gabapentin Paediatric Study Group. Epilepsia 40 : 1147 1154.
4. Arroyo S, Anhut H, Kugler AR, Lee CM, Knapp LE, Garofalo EA, Messmer S, Pregabalin 1008-011 International Study Group 2004) Pregabalin add-on treatment: a randomized, double-blind, placebo-controlled, dose-response study in adults with partial seizures. Epilepsia 45 : 20 27.
5. Asconapé JJ, Penry JK, Dreifuss FE, Riela A, Mirza W 1993) Valproate-associated pancreatitis. Epilepsia 34 : 177 183.
6. Beghi E, Tognoni G 1988) Prognosis of epilepsy in newly referred patients: a multicenter prospective study. Collaborative Group for the Study of Epilepsy. Epilepsia 29 : 236 243.
7. Ben-Menachem E, Henriksen O, Dam M, Mikkelsen M, Schmidt D, Reid S, Reife R, Kramer L, Pledger G, Karim R 1996) Double-blind, placebo-controlled trial of topiramate as add-on therapy in patients with refractory partial seizures. Epilepsia 37 : 539 543.
8. Ben-Menachem E, Falter U 2000) Efficacy and tolerability of levetiracetam 3000 mg/d in patients with refractory partial seizures: a multicenter, double-blind, responder-selected study evaluating monotherapy. European Levetiracetam Study Group. Epilepsia 41 : 1276 1283.
9. Ben-Menachem E, Biton V, Jatuzis D, Abou-Khalil B, Doty P, Rudd GD 2007) Efficacy and safety of oral Lacosamide as adjunctive therapy in adults with partial-onset seizures. Epilepsia 48 : 1308 1317.
10. Besag FM, Dulac O, Alving J, Mullens EL 1997) Long-term safety and efficacy of lamotrigine (Lamictal) in paediatric patients with epilepsy. Seizure 6 : 51 56.
11. Beydoun A, Sachdeo RC, Rosenfeld WE, Krauss GL, Sessler N, Mesenbrink P, Kramer L, D'Souza J 2000) Oxcarbazepine monotherapy for partial-onset seizures: a multicenter, double-blind, clinical trial. Neurology 54 : 2245 2251.
12. Beydoun A, Uthman BM, Kugler AR, Greiner MJ, Knapp LE, Garofalo EA, Pregabalin 1008-009 Study Group 2005) Safety and efficacy of two pregabalin regimens for add-on treatment of partial epilepsy. Neurology 64 : 475 480.
13. Bialer M, Johannessen SI, Kupferberg HJ, Levy RH, Loiseau P, Perucca E 1996) Progress report on new antiepileptic drugs: a summary of the Third Eilat Conference. Epilepsy Res 25 : 299 319.
14. Bialer M, Johannessen SI, Kupferberg HJ, Levy RH, Loiseau P, Perucca E 1999) Progress report on new antiepileptic drugs: a summary of the fourth Eilat conference (EILAT IV). Epilepsy Res 34 : 1 41.
15. Bialer M, Johannessen SI, Kupferberg HJ, Levy RH, Loiseau P, Perucca E 2001) Progress report on new antiepileptic drugs: a summary of the Fifth Eilat Conference (EILAT V). Epilepsy Res 43 : 11 58.
16. Bialer M, Johannessen SI, Kupferberg HJ, Levy RH, Loiseau P, Perucca E 2002) Progress report on new antiepileptic drugs: a summary of the Sixth Eilat Conference (EILAT VI). Epilepsy Res 51 : 31 71.
17. Bialer M, Johannessen SI, Kupferberg HJ, Levy RH, Perucca E, Tomson T 2004) Progress report on new antiepileptic drugs: a summary of the Seventh Eilat Conference (EILAT VII). Epilepsy Res 61 : 1 48.
18. Bialer M, Johannessen SI, Kupferberg HJ, Levy RH, Perucca E, Tomson T 2007) Progress report on new antiepileptic drugs: a summary of the Eighth Eilat Conference (EILAT VIII). Epilepsy Res 73 : 1 52.
19. Bialer M, Johannessen SI, Levy RH, Perucca E, Tomson T, White HS 2009) Progress report on new antiepileptic drugs: a summary of the Ninth Eilat Conference (EILAT IX). Epilepsy Res 83 : 1 43.
20. Bill PA, Vigonius U, Pohlmann H, Guerreiro CA, Kochen S, Saffer D, Moore A 1997) A double-blind controlled clinical trial of oxcarbazepine versus phenytoin in adults with previously untreated epilepsy. Epilepsy Res 27 : 195 204.
21. Binnie CD, van Emde Boas W, Kasteleijn-Nolste-Trenite DG, de Korte RA, Meijer JW, Meinardi H, Miller AA, Overweg J, Peck AW, van Wieringen A, Yuen WC 1986) Acute effects of lamotrigine (BW430C) in persons with epilepsy. Epilepsia 27 : 248 254.
22. Binnie CD, Beintema DJ, Debets RM, Van Emde Boas W, Meijer JW, Meinardi H, Peck AW, Westendorp AM, Yuen WC 1987) Seven day administration of lamotrigine in epilepsy: placebo-controlled add-on trial. Epilepsy Res 1 : 202 208.
23. Bird CAK, Griffen BP, Miklazewska J, Galbraith AW 1966) Tegretol (carbamazepine): a controlled trial of a new anticonvulsant. Br J Psychiatry 112 : 737 742.
24. Biton V, Montouris GD, Ritter F, Riviello JJ, Reife R, Lim P, Pledger G 1999) A randomized, placebo-controlled study of topiramate in primary generalized tonic-clonic seizures: Topiramate YTC Study Group. Neurology 52 : 1330 1337.
25. Blom S 1962) Trigeminal neuralgia: its treatment with a new anticonvulsant drug (G-32883). Lancet 1 : 829 840.
26. Bonduelle M, Bouygues P, Sallou C, Chemaly R 1964) Expérimentation clinique de l'antiépileptique G32882. Résultants portant sur 100 cas observés entrois nas. Rev Neurol 110 : 209 215.
27. Brodie M, Richens A, Yuen AW 1995) Double-blind comparison of lamotrigine and carbamazepine in newly diagnosed epilepsy: UK Lamotrigine/Carbamazepine Monotherapy Trial Group. Lancet 345 : 476 479.
28. Brodie MJ, Overstall PW, Giorgi L 1999) Multicentre, double-blind, randomised comparison between lamotrigine and carbamazepine in elderly patients with newly diagnosed epilepsy: the UK Lamotrigine Elderly Study Group. Epilepsy Res 37 : 81 87.
29. Brodie MJ, Wroe SJ, Dean AD, Holdich TA, Whitehead J, Stevens JW 2002) Efficacy and safety of remacemide versus carbamazepine in newly diagnosed epilepsy: comparison by sequential analysis. Epilepsy Behav 3 : 140 146.
30. Browne TR, Penry JK 1973) Benzodiazepines in the treatment of epilepsy: a review. Epilepsia 14 : 277 310.
31. Buchthal F, Svensmark O 1960) Aspects of the pharmacology of phenytoin (Dilantin) and phenobarbital relevant to their dosage in the treatment of epilepsy. Epilepsia 1 : 373 384.
32. Buchthal F, Svensmark O, Schiller PJ 1960) Clinical and electroencephalographic correlations with serum levels of diphenylhydantoin. Arch Neurol 2 : 624 630.
33. Buchthal F, Svensmark O, Simonsen H 1968) Relation of EEG and seizures to phenobarbital in serum. Arch Neurol 19 : 567 572.
34. Buchthal F, Svensmark O 1971) Serum concentrations of diphenylhydantoin (phenytoin) and phenobarbital and their relation to therapeutic and toxic effects. Psychiatry Neurol Neurochir 74 : 117 136.
35. Canadian Study Group for Childhood Epilepsy 1998) Clobazam has equivalent efficacy to carbamazepine and phenytoin as monotherapy for childhood epilepsy: Canadian Study Group for Childhood Epilepsy. Epilepsia 39 : 952 959.
36. Carraz G, Fau R, Chateau R, Bonnin J 1964) Communication à propos des premiere essays cliniques sur l'activité anti-épileptique de l'acide n-dipropylacétique (Sel de Na). Annales médico- psychologiques 122, 4 : 577 585.
37. Cereghino JJ, Brock JT, Van Meter JC, Penry JK, Smith LD, White BG 1974) Carbamazepine for epilepsy: controlled prospective evaluation. Neurology 24 : 401 410.
38. Cereghino JJ, Biton V, Abou-Khalil B, Dreifuss F, Gauer LJ, Leppik I 2000) Levetiracetam for partial seizures: results of a double-blind, randomized clinical trial. Neurology 55 : 236 242.
39. Chadwick D 1999) Safety and efficacy of vigabatrin and carbamazepine in newly diagnosed epilepsy: a multicentre randomised DB study: Vigabatrin European Monotherapy Study Group. Lancet 354 : 13 19.
40. Chadwick DW, Anhut H, Greiner MJ, Alexander J, Murray GH, Garofalo EA, Pierce MW 1998) A double-blind trial of gabapentin monotherapy for newly diagnosed partial seizures: International Gabapentin Monotherapy Study Group 945-77. Neurology 51 : 1282 1288.
41. Chapman AG, Horton RW, Meldrum BS 1978) Anticonvulsant action of a 1,5-benzodiazepine, clobazam, in reflex epilepsy. Epilepsia 19 : 293 299.
42. Christe W, Kramer G, Vigonius U, Pohlmann H, Steinhoff BJ, Brodie MJ, Moore A 1997) A double-blind controlled clinical trial: oxcarbazepine versus sodium valproate in adults with newly diagnosed epilepsy. Epilepsy Res 26 : 451 460.
43. Chung WH, Hung SI, Hong HS, Hsih MS, Yang LC, Ho HC, Wu JY, Chen YT 2004) Medical genetics: a marker for Stevens-Johnson syndrome. Nature 428 : 486.
44. Coatsworth JJ 1971) Studies on the clinical efficacy of marketed antiepileptic drugs. NINDS Monograph No. 12, DHEW Publication No. (NIH) 73-51. US Government Printing Office, Washington, DC.
45. Cockerell OC, Johnson AL, Sander JW, Shorvon SD 1997) Prognosis of epilepsy: a review and further analysis of the first nine years of the British National General Practice Study of Epilepsy, a prospective population-based study. Epilepsia 38 : 31 46.
46. Cohen AF, Ashby L, Crowley D, Land G, Peck AW, Miller AA 1985) Lamotrigine (BW430C), a potential anticonvulsant: effects on the central nervous system in comparison with phenytoin and diazepam. Br J Clin Pharmacol 20 : 619 629.
47. Commission for the Control of Epilepsy and Its Consequences 1978) Plan for nationwide action in epilepsy. DHEW Publication No. 78-276. US Government Printing Office, Bethesda, MD.
48. Coulter DL, Allen RJ 1980) Secondary hyperammonaemia: a possible mechanism for valproate encephalopathy. Lancet 14 : 1310 1311.
49. Dalens B, Raynaud EJ, Gaulme J 1980) Teratogenicity of valproic acid. Pediatrics 97 : 332 333.
50. Dam M, Ekberg R, Løyning Y, Waltimo O, Jakobsen K 1989) A double-blind study comparing oxcarbazepine and carbamazepine in patients with newly diagnosed, previously untreated epilepsy. J Neurol Neurosurg Psychiatry 52 : 472 476.
51. da Rocha AJ, Reis F, Gama HP, da Silva CJ, Braga FT, Maia AC Jr., Cendes F 2006) Focal transient lesion in the splenium of the corpus callosum in three non-epileptic patients. Neuroradiology 48 : 731 735.
52. de Silva M, MacArdle B, McGowan M, Hughes E, Stewart J, Neville BG, Johnson AL, Reynolds EH 1996) Randomised comparative monotherapy trial of phenobarbitone, phenytoin, carbamazepine, or sodium valproate for newly diagnosed childhood epilepsy. Lancet 347 : 709 713.
53. Dreifuss FE, Santilli N, Langer DH, Sweeney KP, Moline KA, Menander KB 1987) Valproic acid hepatic fatalities: a retrospective review. Neurology 37 : 379 385.
54. Duchowny M, Pellock JM, Graf WD, Billard C, Gilman J, Casale E, Womble G, Risner M, Manasco P 1999) A placebo-controlled trial of lamotrigine add-on therapy for partial seizures in children: Lamictal Pediatric Partial Seizure Study Group. Neurology 53 : 1724 1731.
55. Eke T, Talbot J, Lawden M 1997) Severe persistent visual field constriction associated with vigabatrin. Br Med J 314 : 180 181.
56. Elger CE, Brodie MJ, Anhut H, Lee CM, Barrett JA 2005) Pregabalin add-on treatment in patients with partial seizures: a novel evaluation of flexible-dose and fixed-dose treatment in a double-blind, placebo-controlled study. Epilepsia 46 : 1926 1936.
57. Ellison RH, Placencia M, Guvenor A, Bilgin Y, Feksi A, Sander JWAS, Shorvon SD 1989) A programme of transcultural studies of epilepsy: outline of objectives and study design. In Manelis J, Bental E, Loeber J (Eds) Advances in epileptology: the XVIIth Epilepsy International Congress. Raven Press, New York, pp. 435 440.
58. Elterman RD, Glauser TA, Wyllie E, Reife R, Wu SC, Pledger G 1999) A double-blind, randomized trial of topiramate as adjunctive therapy for partial-onset seizures in children: Topiramate YP Study Group. Neurology 52 : 1338 1344.
59. Eriksson AS, Nergårdh A, Hoppu K 1998) The efficacy of lamotrigine in children and adolescents with refractory generalized epilepsy: a randomized, double-blind, crossover study. Epilepsia 39 : 495 501.
60. Faught E, Wilder BJ, Ramsay RE, Reife RA, Kramer LD, Pledger GW, Karim RM 1996) Topiramate placebo-controlled dose-ranging trial in refractory partial epilepsy using 200-, 400-, and 600-mg daily dosages: Topiramate YD Study Group. Neurology 46 : 1684 1690.
61. Faught E, Ayala R, Montouris GG et al. (2001) Randomized controlled trial of zonisamide for the treatment of refractory partial-onset seizures. Neurology 57 : 1774 1779.
62. Feely M, Calvert R, Gibson J 1982) Clobazam in catamenial epilepsy: a model for evaluating anticonvulsants. Lancet 2 : 71 73.
63. Friedlander WJ, Rottgers E 1951) The effects of cortisone on the Electrocencephalograph. Electrocencephalogr Clin Europhysiol 3 : 311 320.
64. Gastaut H, Naquet R, Poiré R, Tassinari CA 1965) Treatment of status epilepticus with diazepam (valium). Epilepsia 6 : 167 182.
65. Gastaut H, Courjon J, Poiré R, Weber M 1971) Treatment of status epilepticus with a new benzodiazepine more active than diazepam. Epilepsia 12 : 197 214.
66. Gastaut H, Low MD 1979) Antiepileptic properties of clobazam, a 1-5-benzodiazepine, in man. Epilepsia 20 : 437 446.
67. Gilliam FG, Veloso F, Bomhof MA, Gazda SK, Biton V, Ter Bruggen JP, Neto W, Bailey C, Pledger G, Wu SC 2003) A dose-comparison trial of topiramate as monotherapy in recently diagnosed partial epilepsy. Neurology 60 : 196 202.
68. Glauser TA, Nigro M, Sachdeo R, Pasteris LA, Weinstein S, Abou-Khalil B, Frank LM, Grinspan A, Guarino T, Bettis D, Kerrigan J, Geoffroy G, Mandelbaum D, Jacobs T, Mesenbrink P, Kramer L, D'Souza J 2000) Adjunctive therapy with oxcarbazepine in children with partial seizures: the Oxcarbazepine Pediatric Study Group. Neurology 54 : 2237 2244.
69. Glauser T, Ben-Menachem E, Bourgeois B, Cnaan A, Chadwick D, Guerreiro C, Kalviainen R, Mattson R, Perucca E, Tomson T 2006) ILAE treatment guidelines: evidence-based analysis of antiepileptic drug efficacy and effectiveness as initial monotherapy for epileptic seizures and syndromes. Epilepsia 47 : 1094 1120.
70. Gomez MR 1981) Possible teratogenicity of valproic acid. J Pediatr 98 : 508 509.
71. Gram L, Lyon BB, Dam M 1983) Gamma-vinyl-GABA: a single-blind trial in patients with epilepsy. Acta Neurol Scand 68 : 34 39.
72. Gram L, Klosterskov P, Dam M 1985) Gamma-vinyl GABA: a double-blind placebo-controlled trial in partial epilepsy. Ann Neurol 17 : 262 266.
73. Green JR et al. (1974) Sulthiame: evaluation as an anticonvulsant. Epilepsia 15 : 329 349.
74. Guelaen P, Van Der Kleijn E, Woudstra U 1975) Statistical analysis of pharmacokinetic parameters in epileptic patients chronically treated with anti-epileptic drugs. In Schneider H, Janz D, Gardner-Thorpe C, Meinardi H, Sherwin A (Eds) Clinical pharmacology of anti-epileptic drugs. Springer-Verlag, Berlin, pp. 2 10
75. Guerreiro MM, Vigonius U, Pohlmann H, de Manreza ML, Fejerman N, Antoniuk SA, Moore A 1997) A double-blind controlled clinical trial of oxcarbazepine versus phenytoin in children and adolescents with epilepsy. Epilepsy Res 27 : 205 213.
76. Haerer AF, Buchanan RA, Wiygul FM (1970) Ethosuximide blood levels in epileptics.
77. Hansen SE 1963) Quantitative determination of ethosuximide (Zarontin, alpha-methyl, alpha-ethylsuccinimide) in serum. Acta Pharmacol Toxicol 20 : 286 290.
78. Harvey PK, Higenbottam TW, Loh L 1975) Chlormethiazole in treatment of status epilepticus. Br Med J 2 : 603 605.
79. Heathfield KW, Jewesbury EC 1961) Treatment of petit mal with ethosuximide. Br Med J 2 : 565 567.
80. Helferich B, Kleb KG 1960) N-aryl- sulthiame, 1. Liebigs Ann Chem 441 : 427 431.
81. Heller AJ, Chesterman P, Elwes RDC, Crawford P, Chadwick D, Johnson AL, Reynolds EH 1995) Phenobarbitone, phenytoin, carbamazepine, or sodium valproate for newly diagnosed adult epilepsy: a randomised comparative monotherapy trial. J Neurol Neurosurg Psychiatry 58 : 44 50.
82. Hensen JM, Kristensen M, Skovsted L 1968) Sulthiame (Ospolot) as an inhibitor of diphenylhydantoin metabolism. Epilepsia 9 : 17 22.
83. Isojärvi JI, Laatikainen TJ, Pakarinen AJ, Juntunen KT, Myllylä VV 1993) Polycystic ovaries and hyperandrogenism in women taking valproate for epilepsy. N Engl J Med 329 : 1383 1388.
84. Jawad S, Richens A, Goodwin G, Yuen WC 1989) Controlled trial of lamotrigine (Lamictal) for refractory partial seizures. Epilepsia 30 : 356 363.
85. Jongmans JW 1964) Report on the anti-epileptic action of Tegretol. Epilepsia 5 : 74 82.
86. Kälviäinen R, Aikiä M, Saukkonen AM, Mervaala E, Riekkinen PJ Sr. 1995) Vigabatrin vs carbamazepine monotherapy in patients with newly diagnosed epilepsy: randomized, controlled study. Arch Neurol 52 : 989 996.
87. Kälviäinen R, Aikiä M, Mervaala E, Saukkonen AM, Pitkänen A, Riekkinen PJ Sr. 1996) Long-term cognitive and EEG effects of tiagabine in drug-resistant partial epilepsy. Epilepsy Res 25 : 291 297.
88. Kälviäinen R, Brodie MJ, Duncan J, Chadwick D, Edwards D, Lyby K 1998) A double-blind, placebo-controlled trial of tiagabine given three-times daily as add-on therapy for refractory partial seizures. Northern European Tiagabine Study Group. Epilepsy Res 30 : 31 40.
89. Klein R, Livingston S 1950) The effect of adrenocorticotropic hormone in epilepsy. J Pediar 37 : 733 742.
90. Korean Topiramate Study Group 1999) Topiramate in medically intractable partial epilepsies: double-blind placebo-controlled randomized parallel group trial. Epilepsia 40 : 1767 1774.
91. Krall RL, Penry JK, Kupferberg HJ, Swinyard EA 1978) Antiepileptic drug development: I. History and a program for progress. Epilepsia 19 : 393 408.
92. Kumar P, Brand R 2003) Detailing gets personal: integrated segmentation may be pharma's key to 'repersonalizing' the selling process. Pharm Exec 1 August. http://pharmexec.findpharma.com/pharmexec/article/articleDetail.jsp?id= 64071 (accessed 19 October 2008).
93. Kupferberg HJ 1989) Antiepileptic drug development program: a cooperative effort of government and industry. Epilepsia 30 (Suppl 1 S51 S56.
94. Kutt H, Penry JK 1974) Usefulness of blood levels of antiepileptic drugs. Arch Neurol 31 : 283 288.
95. Lamb RJ, Leach MJ, Miller AA, Hardenberg PJ. (1985) Anticonvulsant profile in mice of lamotrigine, a novel anticonvulsant. Br J Pharmacol 85 : 235.
96. Lennox WG 1960) Epilepsy and related disorders. Little Brown, Boston.
97. Leppik IE, Dreifuss FE, Pledger GW, Graves NM, Santilli N, Drury I, Tsay JY, Jacobs MP, Bertram E, Cereghino JJ et al. (1991) Felbamate for partial seizures: results of a controlled clinical trial. Neurology 41 : 1785 1789.
98. Lippert B, Metcalf BW, Jung MJ, Casara P 1977) 4-amino-hex-5-enoic acid, a selective catalytic inhibitor of 4-aminobutyric-acid aminotransferase in mammalian brain. Eur J Biochem 74 : 441 445.
99. Livingston S, Pauli LL, Najmabodi A 1962) Ethosuximide in the treatment of epilepsy. Preliminary report. J Am Med Assoc 180 : 822 825.
100. Livingston S, Torres I, Pauli LL, Rider RV 1965) Petit mal epilepsy: results of a prolonged follow-up study of 117 patients. J Am Med Assoc 194 : 227 232.
101. Livingston S, Rodriguez H, Greene CA, Pauli LL 1968) Systemic lupus erythematosus: occurrence in association with ethosuximide therapy. J Am Med Assoc 204 : 731 732.
102. Loiseau P, Hardenberg JP, Pestre M, Guyot M, Schechter PJ, Tell GP 1986) Double-blind, placebo-controlled study of vigabatrin (gamma-vinyl GABA) in drug-resistant epilepsy. Epilepsia 27 : 115 120.
103. Loiseau P, Yuen AW, Duché B, Ménager T, Arné-Bès MC 1990) A randomised double-blind placebo-controlled crossover add-on trial of lamotrigine in patients with treatment-resistant partial seizures. Epilepsy Res 7 : 136 145.
104. Lorgé M 1964) Epilepsy: results of catamnestic studies. Psychiatry Neurol. 147 : 360 381. Br Med J i : 1635 1637.
105. Luciano AL, Shorvon SD 2007) The results of treatment changes in patients with apparently drug-resistant chronic epilepsy. Ann Neurol 62 : 375 381.
106. MacDonald BK, Johnson AL, Goodridge DM, Cockerell OC, Sander JW, Shorvon SD 2000) Factors predicting prognosis of epilepsy after presentation with seizures. Ann Neurol 48 : 833 841.
107. Mann LB, Hebenicht HA 1962) Fatal bone marrow aplasia associated with the administration of ethosuximide (Zarontin) for petit mal epilepsy. Bull Los Angeles Neurol Soc 27 : 173 176.
108. Marjerrison G, Jedlicki SM, Keogh RP, Hrychuk W, Poulakakis GM 1968) Carbamazepine: behavioral, anticonvulsant and EEG effects in chronically-hospitalized epileptics. Dis Nerv Syst 1968 (29 133 136.
109. Marson AG, Kadir ZA, Hutton JL, Chadwick DW 1997) The new antiepileptic drugs: a systematic review of their efficacy and tolerability. Epilepsia 38 : 859 880.
110. Marson AG, Williamson PR, Taylor S, Maguire M, Chadwick DW 2006) Efficacy of carbamazepine and valproate as monotherapy for early epilepsy and single seizures. Neurology 67 : 1872 1875.
111. Marson AG, Al-Kharusi AM, Alwaidh M, Appleton R, Baker GA, Chadwick DW, Cramp C, Cockerell OC, Cooper PN, Doughty J, Eaton B, Gamble C, Goulding PJ, Howell SJ, Hughes A, Jackson M, Jacoby A, Kellett M, Lawson GR, Leach JP, Nicolaides P, Roberts R, Shackley P, Shen J, Smith DF, Smith PE, Smith CT, Vanoli A, Williamson PR, SANAD Study group 2007a) The SANAD study of effectiveness of valproate, lamotrigine, or topiramate for generalised and unclassifiable epilepsy: an unblinded randomised controlled trial. Lancet 369 : 1016 1026.
112. Marson AG, Al-Kharusi AM, Alwaidh M, Appleton R, Baker GA, Chadwick DW, Cramp C, Cockerell OC, Cooper PN, Doughty J, Eaton B, Gamble C, Goulding PJ, Howell SJ, Hughes A, Jackson M, Jacoby A, Kellett M, Lawson GR, Leach JP, Nicolaides P, Roberts R, Shackley P, Shen J, Smith DF, Smith PE, Smith CT, Vanoli A, Williamson PR, SANAD Study group 2007b) The SANAD study of effectiveness of carbamazepine, gabapentin, lamotrigine, oxcarbazepine or topiramate for treatment of partial epilepsy: an unblended randomised controlled trial. Lancet 369 : 1000 1015.
113. Matsuo F, Bergen D, Faught E, Messenheimer JA, Dren AT, Rudd GD, Lineberry CG 1993) Placebo-controlled study of the efficacy and safety of lamotrigine in patients with partial seizures. U.S. Lamotrigine Protocol 0.5 Clinical Trial Group. Neurology 43 : 2284 2291.
114. Mauguière F, Chauvel P, Dewailly J, Dousse N, the PMS Study Multicenter Group 1997) No effect of long-term vigabatrin treatment on central nervous system conduction in patients with refractory epilepsy: results of a multicenter study of somatosensory and visual evoked potentials. Epilepsia 38 : 301 308.
115. Mbuba CK, Ngugi AK, Newton CR, Carter JA 2008) The epilepsy treatment gap in developing countries: a systematic review of the magnitude, causes, and intervention strategies. Epilepsia 49 : 1491 1503.
116. McLean MJ, Macdonald RL 1986) Carbamazepine and 10,11-epoxycarbamazepine produce use- and voltage-dependent limitation of rapidly firing action potentials of mouse central neurons in cell culture. J Pharmacol Exp Ther 238 : 727 738.
117. Meinardi H 1971) Clinical trials of anti-epileptics drugs. Psychiatry Neurol Neurochir 74 : 141 151.
118. Meldrum B, Horton R 1978) Blockade of epileptic responses in the photosensitive baboon, Papio papio, by two irreversible inhibitors of GABA-transaminase, gamma-acetylenic GABA 4-amino-hex-5-ynoic acid) and gamma-vinyl GABA (4-amino-hex-5-enoic acid). Psychopharmacology 59 : 47 50.
119. Messenheimer J, Ramsay RE, Willmore LJ, Leroy RF, Zielinski JJ, Mattson R, Pellock JM, Valakas AM, Womble G, Risner M 1994) Lamotrigine therapy for partial seizures: a multicenter, placebo-controlled, double-blind, cross-over trial. Epilepsia 35 : 113 121.
120. Meunier H, Carraz G, Meunier Y, Eymard P, Aimard M 1963) Propriétés pharmacodynamiques de l'acide n- dipropylacétique. Thérapie XVIII, 435 : 438.
121. Miller CA, Scholl HI, Long LM 1951) Anticonvulsants II. A study of N, α,β-substituted succinimides. J Am Chem Soc 73 : 5608 5610.
122. Miller CA, Long LM 1953) Anticonvulsants III. A study of N, α,β-substituted alkylsuccinimides. J Am Chem Soc 75 : 373 375.
123. Motte J, Trevathan E, Arvidsson JF, Barrera MN, Mullens EL, Manasco P 1998) Lamotrigine for generalized seizures associated with the Lennox-Gastaut syndrome: Lamictal Lennox-Gastaut Study Group. N Engl J Med 337 : 1807 1812.
124. Muller K 1963) Erythema exudativum multiforme majus (Stevens-Johnson- Syndrome) infolge Suxinutin-Uberempfindlichkeit. Z Kinderheilkd 88 : 548 563.
125. Neligan A, Shorvon SD (2009). The modern history of status epilepticus and its treatment Epilepsia (in press).
126. Nieto-Barrera M, Brozmanova M, Capovilla G, Christe W, Pedersen B, Kane K, O'Neill F, Lamictal vs. Carbamazepine Study Group 2001) A comparison of monotherapy with lamotrigine or carbamazepine in patients with newly diagnosed partial epilepsy. Epilepsy Res 46 : 145 155.
127. Pedley TA, Horton RW, Meldrum BS 1979) Electroencephalographic and behavioral effects of a GABA agonist (muscimol) on photosensitive epilepsy in the baboon, papio papio. Epilepsia 20 : 409 416.
128. Penry JK, Porter RJ, Dreifuss FE 1972) Ethosuximide. Relation of plasma levels to clinical control. In Woodbury DM, Penry JK, Schmidt RP (Eds) Antiepileptic drugs. Raven Press, New York, pp. 431 441
129. Penry JK 1973) Principles for clinical testing of antiepileptic drugs. Epilepsia 14 : 451 458.
130. Penry JK, Rapport RL II. Eds 1973) Epilepsy bibliography, 1900-1950. US Government Printing Office, Washington DC.
131. Poiré R, Royer R, Degraeve M, Rustin C 1963) Traitement des états de ma1 épileptiques par le 'CTZ' base. Rév Neurolog 108 : 112 126.
132. Pryse-Phillips WE, Jeavons PM 1970) Effect of carbamazepine (Tegretol) on the electroencephalograph and ward behaviour of patients with chronic epilepsy. Epilepsia 11 : 263 273.
133. Rajotte P, Jilek W, Jilek L, Perales A, Giard N, Bordeleau JM, Tétreault L 1967) The anti-epileptic and psychotropic properties of carbamazepine (Tegretol). Union Med Can 96 : 1200 1206.
134. Remy C, Favel P, Tell G, Wheatley PL. (1986) Etude en double aveugle contre placébo en permutation croisées du vigabatrin dans l'épilepsie de l'adulte résistant à la thé rapeutique. Boll Lega It Epil 54/55 : 241 243.
135. Reunanen M, Dam M, Yuen AW 1996) A randomised open multicentre comparative trial of lamotrigine and carbamazepine as monotherapy in patients with newly diagnosed or recurrent epilepsy. Epilepsy Res 23 : 149 155.
136. Reynolds EH, Shorvon SD 1981) Monotherapy or polytherapy for epilepsy? Epilepsia 22 : 1 10.
137. Reynolds EH, Milner G, Matthews DM, Chanarin I. (1966) Anticonvulsant therapy, megaloblastic haemopoiesis and folic acid metabolism. QJM 35 : 521 537.
138. Reynolds EH, Chadwick D, Galbraith AW 1976) One drug (phenytoin) in the treatment of epilepsy. Lancet 1 : 923 926.
139. Richens A, Chadwick DW, Duncan JS, Dam M, Gram L, Mikkelsen M, Morrow J, Mengel H, Shu V, McKelvy JF et al. (1995) Adjunctive treatment of partial seizures with tiagabine: a placebo-controlled trial. Epilepsy Res 21 : 37 42.
140. Rimmer EM, Richens A 1984) Double-blind study of gamma-vinyl GABA in patients with refractory epilepsy. Lancet 1 : 189 190.
141. Ring H, Reynolds EH 1992) Vigabatrin. In Pedley TA, Meldrum BS (Eds) Recent advances in epilepsy, Vol. 5, Churchill Livingstone, Edinburgh, pp. 177 195.
142. Robert E, Guibaud P 1982) Maternal valproic acid and congenital neural tube defects. Lancet 2 : 937.
143. Rodin EA, Rim CS, Rennick PM 1974) The effects of carbamazepine on patients with psychomotor epilepsy: results of a double-blind study. Epilepsia 15 : 547 561.
144. Rosenstein IN 1960) A new psychosedative (librium) as an anticonvulsant in grand mal type convulsive seizures. Dis Nerv Syst 21 (Suppl 57 60.
145. Rowan AJ, Meijer JW, de Beer-Pawlikowski N, van der Geest P, Meinardi H 1983) Valproate-ethosuximide combination therapy for refractory absence seizures. Arch Neurol 40 : 797 802.
146. Rzany B, Correia O, Kelly JP, Naldi L, Auquier A, Stern R 1999) Risk of Stevens-Johnson syndrome and toxic epidermal necrolysis during first weeks of antiepileptic therapy: a case-control study. Study Group of the International Case Control Study on Severe Cutaneous Adverse Reactions. Lancet 354 : 1033 1034.
147. Sachdeo RC, Leroy RF, Krauss GL, Drake ME Jr., Green PM, Leppik IE, Shu VS, Ringham GL, Sommerville KW 1997) Tiagabine therapy for complex partial seizures: a dose-frequency study. The Tiagabine Study Group. Arch Neurol 54 : 595 601.
148. Sachdeo RC, Glauser TA, Ritter F, Reife R, Lim P, Pledger G 1999) A double-blind, randomized trial of topiramate in Lennox-Gastaut syndrome: Topiramate YL Study Group. Neurology 52 : 1882 1887.
149. Sachdeo R, Beydoun A, Schachter S, Vazquez B, Schaul N, Mesenbrink P, Kramer L, D'Souza J 2001) Oxcarbazepine (Trileptal) as monotherapy in patients with partial seizures. Neurology 57 : 864 871.
150. Sander JW, Patsalos PN, Oxley JR, Hamilton MJ, Yuen WC 1990) A randomised double-blind placebo-controlled add-on trial of lamotrigine in patients with severe epilepsy. Epilepsy Res 6 : 221 226.
151. Sander JW, Hart YM, Trimble MR, Shorvon SD 1991) Vigabatrin and psychosis. J Neurol Neurosurg Psychiatry 54 : 435 439.
152. Schachter SC, Vazquez B, Fisher RS, Laxer KD, Montouris GD, Combs-Cantrell DT, Faught E, Willmore LJ, Morris GL, Ojemann L, Bennett D, Mesenbrink P, D'Souza J, Kramer L 1999) Oxcarbazepine: double-blind, randomized, placebo-control, monotherapy trial for partial seizures. Neurology 52 : 732 737.
153. Schapel GJ, Beran RG, Vajda FJ, Berkovic SF, Mashford ML, Dunagan FM, Yuen WC, Davies G 1993) Double-blind, placebo controlled, crossover study of lamotrigine in treatment resistant partial seizures. J Neurol Neurosurg Psychiatry 56 : 448 453.
154. Schauf CL, Davis FA, Marder J 1974) Effects of carbamazepine on the ionic conductances of Myxicola giant axons. J Pharmacol Exp Ther 189 : 538 543.
155. Schechter PJ, Tranier Y, Jung MJ, Böhlen P 1977) Audiogenic seizure protection by elevated brain GABA concentration in mice: effects of gamma-acetylenic GABA and gamma-vinyl GABA, two irreversible GABA-T inhibitors. Eur J Pharmacol 45 : 319 328.
156. Schindler W, Häfliger F 1954) Über Derivate des Iminodibenzyls. Helv Chim Acta 37 : 472 483.
157. Schmidt D, Jacob R, Loiseau P, Deisenhammer E, Klinger D, Despland A, Egli M, Bauer G, Stenzel E, Blankenhorn V 1993) Zonisamide for add-on treatment of refractory partial epilepsy: a European double-blind trial. Epilepsy Res 15 : 67 73.
158. Shah J, Shellenberger K, Canafax DM 2002) Zonisamde. In Levy RH, Mattson R, Meldrum BS, Perucca E (Eds) Antiepileptic Drugs. 5th ed. Lippincott Williams & Wilkins, Philadelphia, pp. 873.
159. Sharief M, Viteri C, Ben-Menachem E, Weber M, Reife R, Pledger G, Karim R 1996) Double-blind, placebo-controlled study of topiramate in patients with refractory partial epilepsy. Epilepsy Res 25 : 217 224.
160. Sherwin AL, Robb JP, Lechter M 1973) Improved control of epilepsy by monitoring plasma ethosuximide. Arch Neurol 28 : 178 181.
161. Shorvon SD, Reynolds EH (1977) Unnecessary polypharmacy in the treatment of epilepsy. Br Med J i : 1635 1637.
162. Shorvon SD, Chadwick D, Galbraith A, Reynolds EH 1978) One drug for epilepsy. Br Med J i : 474.
163. Shorvon SD, Reynolds EH 1979) Reduction of polypharmacy for epilepsy. Br Med J i : 1023.
164. Shorvon SD, Johnson AL, Reynolds EH 1981) Statistical and theoretical considerations in the design of anticonvulsant trials. In Dam M, Gram L, Penry JK (Eds) Advances in Epileptology: The XIIth Epilepsy International Symposium. Raven Press, New York, pp. 123 128.
165. Shorvon SD 1984) The temporal aspects of prognosis in epilepsy. J Neurol Neurosurg Psychiatry 47 : 1157 1165.
166. Shorvon SD, Farmer PJ 1988) Epilepsy in developing countries: a review of epidemiological, socio-cultural and treatment aspects. Epilepsia 29 : 36 54.
167. Shorvon SD 1989) Clobazam. In Levy R, Dreifuss F, Mattson R, Meldrum B, Penry JK (Eds) Antiepileptic drugs. 3rd ed. Raven Press, New York, pp. 821 840
168. Shorvon SD 1995) Clobazam. In Levy H, Mattson RH, Meldrum BS (Eds) Antiepileptic drugs. 4th ed. Raven Press, New York, pp. 763 777.
169. Shorvon SD, Löwenthal A, Janz D, Bielen E, Loiseau P 2000) Multicenter double-blind, randomized, placebo-controlled trial of levetiracetam as add-on therapy in patients with refractory partial seizures: European Levetiracetam Study Group. Epilepsia 41 : 1179 1186.
170. Shorvon SD 2001) New drug classes: pyrrolidone derivatives. Lancet 358 : 1885 1892.
171. Shorvon SD 2006) We live in the age of the clinical guideline. Epilepsia 47 : 1091 1093.
172. Shorvon SD 2009) Preface: The drug treatment of epilepsy 1955-2009. In Shorvon SD, Perucca E, Engel J (Eds) (2009) The treatment of epilepsy. 3rd ed. Wiley-Blackwell, Oxford, In press.
173. Shorvon SD, Perucca E, Engel J 2009a) The treatment of epilepsy. 3rd ed. Wiley-Blackwell, Oxford.
174. Shorvon SD, Weiss G, Avanzini G, Engel P, Meinardi H, Moshe S, Reynolds E, Wolf P 2009b) International League Against Epilepsy (ILAE) 1909-2009: a centenary history. Wiley-Blackwell, Oxford.
175. Sillanpaa M, Schmidt D 2006) Natural history of treated childhood-onset epilepsy: prospective, long term population based study. Brain 129 : 617 624.
176. Silvenius J, Kälviäinen R, Ylinen A, Riekkinen P 1991) Double-blind study of Gabapentin in the treatment of partial seizures. Epilepsia 32 : 539 542.
177. Simon D, Penry JK 1975) Sodium di-N-propylacetate (DPA) in the treatment of epilepsy: a review. Epilepsia 16 : 549 573.
178. Simonsen N, Olsen PZ, Kühl V, Lund M, Wendelboe J 1975) Carbamazepine versus phenytoin in psychomotor epilepsy. A double-blind study of antiepileptic effect and side-effects. Ugeskr Laeger 137 : 2392 2396.
179. Sirven JI, Drazkowski JF, Zimmerman RS, Bortz JJ, Shulman DL, Macleish M 2003) Complementary/alternative medicine for epilepsy in Arizona. Neurology 61 : 576 577.
180. Sorel L, Dusaucy-Bauloye A 1958) Findings in 21 cases of Gibbs' hypsarrhythmia: spectacular effectiveness of AC.TH. Acta Neurol Psychiatr Belg 58 : 130 141.
181. Stables JP, Bialer M, Johannessen SI, Kupferberg HJ, Levy RH, Loiseau P, Perucca E 1995) Progress report on new antiepileptic drugs: a summary of the Second Eilat Conference. Epilepsy Res 22 : 235 246.
182. Steinman MA, Bero LA, Chren MM, Landefeld CS 2006) Narrative review: the promotion of gabapentin: an analysis of internal industry documents. Ann Intern Med 145 : 284 293.
183. Sternbach L 1980) The story of the benzodiazepines. In Priest RG, Vianna Filho U, Amrein R, Skreta M (Eds) Benzodiazepines Today and Tomorrow. Proceedings of the 1st International Symposium on Benzodiazepines in Rio De Janeiro, 28-30 September 1979. MTP Press, Lancaster, UK, pp. 5 18.
184. Suzuki M, Maruyama H, Ishibashi Y, Ogawa S, Seki T, Hoshino M, Maekawa K, Yo T, Sato Y 1972) A double-blind comparative trial of sodium dipropylacetate and ethosuximide in epilepsy in children - with special emphasis on pure petit mal seizure (in Japanese). Med Prog 82 : 470 488.
185. Svensmark O, Buchthal F 1963) Accumulation of Phenobarbital in man. Epilepsia 4 : 199 206.
186. Svensmark O, Buchthal F 1964) Diphenylhydantoin and phenobarbital serum levels in children. Am J Dis Child 108 : 82 87.
187. Swinyard EA, Sofia RD, Kupferberg HJ 1986) Comparative anticonvulsant activity and neurotoxicity of felbamate and four prototype antiepileptic drugs in mice and rats. Epilepsia 27 : 27 34.
188. Tartara A, Manni R, Galimberti CA, Hardenberg J, Orwin J, Perucca E 1986) Vigabatrin in the treatment of epilepsy: a double-blind, placebo-controlled study. Epilepsia 27 : 717 723.
189. Tassinari CA, Michelucci R, Ambrosetto G, Salvi F 1987) Double-blind study of vigabatrin in the treatment of drug-resistant epilepsy. Arch Neurol 44 : 907 910.
190. Tassinari CA, Michelucci R, Chauvel P, Chodkiewicz J, Shorvon S, Henriksen O, Dam M, Reife R, Pledger G, Karim R 1996) Double-blind, placebo-controlled trial of topiramate (600 mg daily) for the treatment of refractory partial epilepsy. Epilepsia 37 : 763 768.
191. The US Gabapentin Study Group No. 5 1993) Gabapentin as add-on therapy in refractory partial epilepsy: a double-blind, placebo-controlled, parallel-group study. Neurology 43 : 2292 2298.
192. Third and Fourth Commissions on Antiepileptic Drugs, International League Against Epilepsy (1985) Availability and distribution of antiepileptic drugs in developing countries. Epilepsia 6 : 117 121.
193. Thomas R 1998) Dr J Kiffin Penry. NY Times, April.
194. Troupin A, Ojemann LM, Halpern L, Dodrill C, Wilkus R, Friel P, Feigl P 1977) Carbamazepine - a double-blind comparison with phenytoin. Neurology 27 : 511 519.
195. Turner WA 1907) Epilepsy: a study of the idiopathic disease. Macmillan, London.
196. UK Gabapentin Study Group 1990) Gabapentin in partial epilepsy. Lancet 335 : 1114 1117.
197. Uthman BM, Rowan AJ, Ahmann PA, Leppik IE, Schachter SC, Sommerville KW, Shu V 1998) Tiagabine for complex partial seizures: a randomized, add-on, dose-response trial. Arch Neurol 55 : 56 62.
198. Vossen R 1958) Anticonvulsant effect of succinimides. Dtsch Med Wochenschr 83 : 1227 1230.
199. Wang WZ, Wu JZ, Ma GY, Dai XY, Yang B, Wang TP, Yuan CL, Hong Z, Bell GS, Prilipko L, de Boer HM, Sander JW 2006) Efficacy assessment of phenobarbital in epilepsy: a large community-based intervention trial in rural China. Lancet Neurol 5 : 46 52.
200. Wechsler IS 1940) Intravenous injection of paraldehyde for the control of convulsions. J Am Med Assoc 113 : 2198.
201. Wheless JW, Neto W, Wang S, EPMN-105 Study Group 2004) Topiramate, carbamazepine, and valproate monotherapy: double-blind comparison in children with newly diagnosed epilepsy. J Child Neurol 19 : 135 141.
202. Whitehead J, Stevens J, Brodie M, Wroe S, Dean A, Holdich T 2002) Remacemide versus carbamazepine in newly diagnosed epilepsy. Epilepsy Behav 3 : 405 406.
203. World Health Organization 2005) Atlas: epilepsy care in the world. WHO, Geneva.
204. Worms P, Depoortere H, Durand A, Morselli PL, Lloyd KG, Bartholini G 1982) gamma-Aminobutyric acid (GABA) receptor stimulation. I. Neuropharmacological profiles of progabide (SL 76002) and SL 75102, with emphasis on their anticonvulsant spectra. J Pharmacol Exp Ther 220 : 660 671.
205. Yen DJ, Yu HY, Guo YC, Chen C, Yiu CH, Su MS 2000) A double-blind, placebo-controlled study of topiramate in adult patients with refractory partial epilepsy. Epilepsia 41 : 1162 1166.
206. Zimmerman FT 1951) Use of methylphenyl-succinimide in treatment of petit mal epilepsy. Arch Neurol Psychiatry 66 : 156 162.
207. Zimmerman FT 1953) New drugs in the treatment of petit mal epilepsy. Am J Psychiatry 109 : 767 773.
208. Zimmerman FT 1954) Milontin and other new drugs in the treatment of petit mal epilepsy. South Med J 47 : 929 935.
209. Zimmerman FT, Burgemeister BB 1958) A new drug for petit mal epilepsy. Neurology 8 : 769 775.